Current genetic engineering technology that based on complementary base pairing for target recognition is a powerful tool to control protein expression at DNA or RNA levels. Nonetheless, limited research has utilized genetic strategies to directly manipulate proteins. To address this gap, we have developed a method of genetically engineered RNA inducers of proximity (GENRIP), one strategy that leverages RNA structure-dependent protein recognition to precisely regulate protein activity. GENRIP is a modular and bifunctional RNA comprising two kinds of motifs: a conserved RNA motif that recruits endogenous RNA-binding enzymes for protein modification, and a variable motif responsible for recognizing different proteins of interest (POIs). By inducing proximity between effector enzymes and POIs, GENRIP enables precise post-translational modification of POIs. Using the RNA-binding E3 ligase MEX3A and RNA-binding kinase CamK as model effectors, we have demonstrated its capability to achieve ubiquitination-mediated degradation and phosphorylation-induced activation of POI, respectively. Furthermore, GENRIP offers superior advantages in modularity, programmability, precise subcellular localization targeting, and cell-type selectivity. This approach represents a paradigm shift in genetic engineering, holding profound implications in the field of post-translational protein regulation. Current genetic engineering techniques enable protein modulation at the DNA/RNA levels. Here, the authors design an RNA platform to bring target protein and effector enzyme into proximity, realizing direct protein regulation.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: